pimavanserin | Pimavanserin

Keyword	CPC	PCC	Volume	Score	Length of keyword
pimavanserin	1.74	0.9	4452	19	12

Keyword	CPC	PCC	Volume	Score
pimavanserin	0.09	0.6	1748	60
pimavanserin tartrate	1.63	1	1868	24
pimavanserin mechanism of action	0.58	0.3	2233	47
pimavanserin cost	1.09	0.5	1921	41
pimavanserin dose	0.42	0.4	5235	76
pimavanserin brand name	0.32	0.8	9252	65
pimavanserin moa	1.72	0.4	4290	55
pimavanserin side effects	0.16	0.6	4775	55
pimavanserin drug class	0.52	0.6	5748	73
pimavanserin alzheimer's	1.07	1	8953	50
pimavanserina para que sirve	0.27	0.9	3765	85
pimavanserin for lewy body dementia	0.71	0.8	663	14
pimavanserin package insert	0.53	1	5241	2

Search Results related to pimavanserin on Search Engine

Pimavanserin - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Pimavanserin

WEBPimavanserin, sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer's disease psychosis, schizophrenia, agitation, and major depressive disorder.

DA: 79 PA: 53 MOZ Rank: 14

Pimavanserin - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK557712/

WEBMay 1, 2023 · Pimavanserin is a medication used to treat and manage the hallucinations and delusions associated with Parkinson disease psychosis. It is in the atypical antipsychotic class of drugs. This activity reviews the indication, action, and contraindications for pimavanserin as a valuable agent in managing Parkinson disease …

DA: 86 PA: 23 MOZ Rank: 1

NUPLAZID® (pimavanserin) - Parkinson's-Related Hallucinations …
nuplazid.com

https://www.nuplazid.com/

WEBParkinson's-Related Hallucinations and Delusions Treatment | NUPLAZID® (pimavanserin) A dedicated Care Coordinator will assist you with accessing and affording your medication. NUPLAZID ® is an FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis.

DA: 65 PA: 80 MOZ Rank: 87

Pimavanserin Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/pimavanserin.html

WEBAug 16, 2023 · What is pimavanserin? Pimavanserin is an antipsychotic medicine that works by changing the actions of chemicals in the brain. Pimavanserin is used to treat hallucinations and delusions caused by psychosis that is related to Parkinson's disease. Pimavanserin may also be used for purposes not listed in this medication guide.

DA: 77 PA: 3 MOZ Rank: 27

FDA approves first drug to treat hallucinations and delusions
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-hallucinations-and-delusions-associated-parkinsons-disease

WEBApril 29, 2016. The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis...

DA: 81 PA: 24 MOZ Rank: 92

Pimavanserin: A Truly Effective Treatment for Parkinson’s …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239266/

WEBMay 30, 2023 · Medical treatment is limited to few atypical antipsychotic drugs with low affinity to dopamine D2 receptors. In 2016, pimavanserin, a selective 5-HT2A inverse agonist/antagonist, was approved by the US Food and Drug Administration (FDA) as the only treatment for PD psychosis (PDP).

DA: 45 PA: 21 MOZ Rank: 6

Pimavanserin (Oral Route) Description and Brand Names - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/drugs-supplements/pimavanserin-oral-route/description/drg-20311664

WEBApr 1, 2024 · Descriptions. Pimavanserin is used to treat hallucinations and delusions caused by Parkinson disease psychosis. It works in the brain to prevent hallucinations and delusions. Pimavanserin should not be used to treat behavioral problems in older adults who have dementia.

DA: 83 PA: 71 MOZ Rank: 67

Pimavanserin: MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a616032.html

WEBPimavanserin is used to treat hallucinations and delusions in people with psychosis from Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Pimavanserin is in a class of medications called atypical antipsychotics.

DA: 67 PA: 66 MOZ Rank: 31

Pimavanserin (Nuplazid™) for the treatment of Parkinson disease
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007714/

WEBMar 23, 2018 · Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis (PDP). 1 Pimavanserin is reported to be a selective inverse agonist at serotonin 5-HT 2a receptors and an antagonist at 5-HT 2c receptors, with a 40-fold higher affinity …

DA: 62 PA: 78 MOZ Rank: 36

Pimavanserin: Uses, Interactions, Mechanism of Action
drugbank.com

https://go.drugbank.com/drugs/DB05316

WEBPimavanserin is a second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease. Brand Names. Nuplazid. Generic Name. Pimavanserin. DrugBank Accession Number. DB05316. Background.

DA: 82 PA: 47 MOZ Rank: 3